Literature DB >> 24947020

Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.

A Nicolae1, L Xi2, S Pittaluga1, Z Abdullaev3, S D Pack3, J Chen4, T A Waldmann4, E S Jaffe1, M Raffeld2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24947020      PMCID： PMC7701980          DOI： 10.1038/leu.2014.200

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells.

Authors:  Y Sandberg; J Almeida; M Gonzalez; M Lima; P Bárcena; T Szczepañski; E J van Gastel-Mol; H Wind; A Balanzategui; J J M van Dongen; J F San Miguel; A Orfao; A W Langerak
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

3.  STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors.

Authors:  Hyun-Mee Oh; Cheng-Rong Yu; Nady Golestaneh; Ahjoku Amadi-Obi; Yun Sang Lee; Amarachi Eseonu; Rashid M Mahdi; Charles E Egwuagu
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia.

Authors:  R S Ohgami; L Ma; J D Merker; B Martinez; J L Zehnder; D A Arber
Journal:  Leukemia       Date:  2013-04-08       Impact factor: 11.528

5.  Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Authors:  M Kontro; H Kuusanmäki; S Eldfors; T Burmeister; E I Andersson; O Bruserud; T H Brümmendorf; H Edgren; B T Gjertsen; M Itälä-Remes; S Lagström; O Lohi; T Lundán; J M L Martí; M M Majumder; A Parsons; T Pemovska; H Rajala; K Vettenranta; O Kallioniemi; S Mustjoki; K Porkka; C A Heckman
Journal:  Leukemia       Date:  2014-02-27       Impact factor: 11.528

Review 6.  The role of STAT5 in lymphocyte development and transformation.

Authors:  Lynn M Heltemes-Harris; Michael A Farrar
Journal:  Curr Opin Immunol       Date:  2012-02-16       Impact factor: 7.486

7.  Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.

Authors:  Marion Travert; Yenlin Huang; Laurence de Leval; Nadine Martin-Garcia; Marie-Helene Delfau-Larue; Françoise Berger; Jacques Bosq; Josette Brière; Jean Soulier; Elizabeth Macintyre; Teresa Marafioti; Aurélien de Reyniès; Philippe Gaulard
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

8.  Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Authors:  Suhu Liu; Sarah R Walker; Erik A Nelson; Robert Cerulli; Michael Xiang; Patricia A Toniolo; Jun Qi; Richard M Stone; Martha Wadleigh; James E Bradner; David A Frank
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Samuli Eldfors; Heikki Kuusanmäki; Arjan J van Adrichem; Thomas Olson; Sonja Lagström; Emma I Andersson; Andres Jerez; Michael J Clemente; Yiyi Yan; Dan Zhang; Andy Awwad; Pekka Ellonen; Olli Kallioniemi; Krister Wennerberg; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Caroline Heckman; Satu Mustjoki
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

10.  STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.

Authors:  Andres Jerez; Michael J Clemente; Hideki Makishima; Hanna Koskela; Francis Leblanc; Kwok Peng Ng; Thomas Olson; Bartlomiej Przychodzen; Manuel Afable; Ines Gomez-Segui; Kathryn Guinta; Lisa Durkin; Eric D Hsi; Kathy McGraw; Dan Zhang; Marcin W Wlodarski; Kimmo Porkka; Mikkael A Sekeres; Alan List; Satu Mustjoki; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113
View more
  52 in total

1.  Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Authors:  Madhu P Menon; Alina Nicolae; Hillary Meeker; Mark Raffeld; Liqiang Xi; Armin G Jegalian; Douglas C Miller; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

Review 2.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 3.  Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

Authors:  Russell James Hubbard Ryan; Ryan Alan Wilcox
Journal:  Hematol Oncol Clin North Am       Date:  2019-05-18       Impact factor: 3.722

4.  T-cell and NK-cell neoplasms of the gastrointestinal tract - recurrent themes, but clinical and biological distinctions exist.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

5.  High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia.

Authors:  Emma I Andersson; Takahiro Tanahashi; Nodoka Sekiguchi; Vanessa Rebecca Gasparini; Sabrina Bortoluzzi; Toru Kawakami; Kazuyuki Matsuda; Takeki Mitsui; Samuli Eldfors; Stefania Bortoluzzi; Alessandro Coppe; Andrea Binatti; Sonja Lagström; Pekka Ellonen; Noriyasu Fukushima; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Hideyuki Nakazawa; Yok-Lam Kwong; Thomas P Loughran; Jaroslaw P Maciejewski; Satu Mustjoki; Fumihiro Ishida
Journal:  Blood       Date:  2016-10-03       Impact factor: 22.113

Review 6.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

7.  The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.

Authors:  Hanna L M Rajala; Thomas Olson; Michael J Clemente; Sonja Lagström; Pekka Ellonen; Tuija Lundan; David E Hamm; Syed Arshi Uz Zaman; Jesus M Lopez Marti; Emma I Andersson; Andres Jerez; Kimmo Porkka; Jaroslaw P Maciejewski; Thomas P Loughran; Satu Mustjoki
Journal:  Haematologica       Date:  2014-10-03       Impact factor: 9.941

8.  The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5.

Authors:  Darshana Kadekar; Rasmus Agerholm; John Rizk; Heidi A Neubauer; Tobias Suske; Barbara Maurer; Monica Torrellas Viñals; Elena M Comelli; Amel Taibi; Richard Moriggl; Vasileios Bekiaris
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 9.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

Review 10.  Central Nervous System Involvement in Peripheral T Cell Lymphoma.

Authors:  Dai Chihara; Yasuhiro Oki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.